LANCL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.319800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.434100E-02
Normal-vs-Stage2
7.148200E-02
Normal-vs-Stage3
7.102300E-02
Normal-vs-Stage4
3.937200E-01
Stage1-vs-Stage2
7.457400E-01
Stage1-vs-Stage3
1.186390E-01
Stage1-vs-Stage4
2.053600E-01
Stage2-vs-Stage3
2.244300E-04
Stage2-vs-Stage4
2.808200E-01
Stage3-vs-Stage4
3.942500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.018000E-02
Normal-vs-AfricanAmerican
1.586970E-01
Normal-vs-Asian
8.318500E-02
Caucasian-vs-AfricanAmerican
8.835000E-01
Caucasian-vs-Asian
5.863600E-01
AfricanAmerican-vs-Asian
6.735200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.620400E-02
Normal-vs-Female
1.091020E-01
Male-vs-Female
3.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.263800E-02
Normal-vs-Age(41-60Yrs)
9.168000E-02
Normal-vs-Age(61-80Yrs)
5.831900E-02
Normal-vs-Age(81-100Yrs)
1.277510E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.824400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.036600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.337600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.225790E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.057500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.807400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.965500E-02
Normal-vs-Daily Drinker
3.603300E-03
Normal-vs-Weekly Drinker
4.325600E-01
Normal-vs-Occasional Drinker
1.066030E-01
Normal-vs-Social Drinker
1.649380E-01
Non Drinker-vs-Daily Drinker
3.868800E-01
Non Drinker-vs-Weekly Drinker
3.516800E-01
Non Drinker-vs-Occasional Drinker
2.403000E-01
Non Drinker-vs-Social Drinker
3.732200E-01
Daily Drinker-vs-Weekly Drinker
1.772570E-01
Daily Drinker-vs-Occasional Drinker
4.436000E-02
Daily Drinker-vs-Social Drinker
1.111750E-01
Weekly Drinker-vs-Occasional Drinker
7.914600E-01
Weekly Drinker-vs-Social Drinker
7.378400E-01
Occasional Drinker-vs-Social Drinker
9.004000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.202500E-02
Normal-vs-Grade 2
1.276100E-02
Normal-vs-Grade 3
1.164350E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.022810E-01
Grade 1-vs-Grade 3
3.210300E-02
Grade 1-vs-Grade 4
4.202500E-02
Grade 2-vs-Grade 3
3.332000E-01
Grade 2-vs-Grade 4
1.276100E-02
Grade 3-vs-Grade 4
1.164350E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.085800E-02
Normal-vs-NonDiabetic
3.081600E-02
Diabetic-vs-NonDiabetic
9.273800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.491940E-02
Normal-vs-NoPancreatitis
4.642300E-02
Pancreatitis-vs-NoPancreatitis
6.001000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.915900E-02
Normal-vs-N1
7.056400E-02
N0-vs-N1
3.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.870440E-01
Normal-vs-TP53-NonMutant
1.675840E-01
TP53-Mutant-vs-TP53-NonMutant
8.176800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
